Compare HP Inc (HPQ) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HP Inc vs Regeneron Pharmaceuticals Inc — how do they compare? HP Inc trades at $24.86 (market cap $22.15B), while Regeneron Pharmaceuticals Inc trades at $680.5 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 3.2× HP Inc's market cap, and HP Inc pays the higher dividend (4.95%). Which is the better fit depends on your goals.
| HPQ | REGN | |
|---|---|---|
Market Cap | $22.15B | $70.47B |
Sector | Technology | Health |
52-Week High | $29.35 | $812.27 |
52-Week Low | $18.20 | $545.46 |
Enterprise Value | $29.31B | $64.42B |
Dividend Yield | 4.95% | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HP Inc
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
